Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

ACS sheet industry - Industry tailwinds to sustain - ICICI Securities

Posted On: 2020-10-25 23:46:36

We expect the asbestos cement sheet (ACS) industry to continue witnessing strong demand and pricing tailwinds in FY21 on the back of healthy rural demand. Being an oligopoly industry with the top-6 players accounting for ~80% of the industry size (Rs39bn, or 3.6mn-mtpa), we believe players with pan-India presence (HIL, Visaka, and Everest) are likely to witness strong earnings growth in FY21E. Besides healthy demand, pricing in the industry too held up in Q2 and Q3-TD (despite being seasonally weak quarters) and is expected to remain firm through the current fiscal. Our recent channel checks suggest: a) strong double-digit volume growth achieved by HIL in Q2FY21 while Visaka Industries and Everest Industries registered flat to low single-digit volume growth; and b) HIL's pricing is somewhat higher (QoQ) compared to its immediate peers.

- Higher rural income and steel sheet prices (alternative to ACS) to drive ACS industry growth over FY20-FY22E. Demand tailwind in ACS is likely to be driven by: 1) higher farm income through recent hike in MSP prices and back to back better monsoons; 2) migration of workers to rural areas in the wake of Covid breakout and higher allocation of Covid relief funds for rural India; 3) firm domestic steel prices (boosted by the adverse sentiment on China) making steel sheet prices relatively higher vs ACS. With these firm drivers likely to sustain in the near term, we expect ACS industry volumes to grow at 5-7% in FY21.

- ACS pricing remains unusually firm in an otherwise off-season period. Our channel checks across regions indicate ACS pricing is down by a mere 4-5% QoQ after rising by ~15% in Q1FY21. This limited price decline is due to sustained demand from rural India and firm pricing in steel-coated sheets. We thus expect Q2/Q3 realisations for top pan-India ACS players to show a high single-digit to low double-digit growth YoY in the current fiscal. If the strong demand sustains into Q4 (which marks the onset of seasonal demand) as well, we might witness ACS pricing to trend incrementally higher, which would drive strong realisations and profitability for the top ACS players in FY21.

- VSKI and HIL to be the biggest beneficiaries of industry tailwinds. We expect VSKI to sustain its strong volumes and profitability in its ACS segment in the current fiscal. HIL on the other hand is likely to stage a strong comeback after having faced muted demand and challenges w.r.t. sourcing of asbestos fibre in the base year (FY20). While Everest too would benefit from the industry tailwinds, it is likely to post lower earnings growth among its top peers (HIL and VSKI) due to higher volumes in the base year and aggressive pricing.

- Maintain BUY on VSKI with target price at Rs552. We expect VSKI to report overall revenue and PAT CAGRs of 6.3% and 27.2% respectively over FY20- FY22E. Higher profitability and stricter working capital discipline leading to sizeable paring of debt would aid VSKI in improving its RoCEs to 15%. We maintain BUY on the stock with an unchanged target price of Rs552, valuing it at 12x FY22E earnings.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Gujarat Gas - Nov 25, 2020 - Angel Broking

Metropolis Healthcare - Nov 25, 2020 - Angel Broking

NTPC - Showcase of strength & competitiveness - ICICI Securities

Telecom - Market Share TRACKER - Bharti is narrowing the gap on incremental market share vs RJio - ICICI Securities

Cochin Shipyard - Q2FY21 Result Update - ICICI Direct

Engineers India - Q2FY21 Result Update - ICICI Direct

Rupee - Nov 24, 2020 - Reliance Securities

FMCG Sector Update - Recovery unlocked; lower growth divergence - HDFC Securities

Engineers India - Consultancy segment outperformance - ICICI Securities

Engineers India - Q2 FY21 Result Update - YES SECURITIES

Motherson Sumi Systems - Company Update - Virtual Investor Conference - ICICI Direct

Mutual Fund Review - November, 2020 - ICICI Direct

Sadbhav Engineering - Q2FY21 Company Update - ICICI Direct

IRB Infrastructure - Q2FY21 Company Update - ICICI Direct

Vodafone Idea fund raising - Angel Broking

Rupee - Nov 23, 2020 - Reliance Securities

Crude Oil - Nov 23, 2020 - Reliance Securities

Q2FY21 Bank Result Quick Review - Angel Broking

Banks & NBFC's Sector Update Report - Yet another watershed moment? - HDFC Securities

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Diagnostics - COVID-19 tests continue to trend higher - ICICI Securities

Banking & Financial Services - Sector Update - Nov 22, 2020 - ICICI Direct

Dalmia Bharat Sugar - Q2FY21 Company Update - ICICI Direct

Balkrishna Industries - Industry export growth momentum continues - ICICI Securities

Covid Recovery Pulse - Festive positivity continues in auto retails, E-way bill generation improves... - ICICI Direct

Quant Pick - Exide Industries - ICICI Direct

Shankara Building Products - Q2FY21 Company Update - ICICI Direct

Triveni Engineering - Q2FY21 Company Update - ICICI Direct

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Earnings Wrap Q2FY21: Earnings outperform, post Covid recovery picks up steam - ICICI Direct

Vodafone Idea Positive development beneficial for IDFC first bank - Angel Broking

Lakshmi Vilas Bank - Angel Broking

WIPRO Buyback record date announcement - Angel Broking

TCS buyback record date announcement - Angel Broking

Banks Sector Update - Collection efficiency - a positive surprise! - HDFC Securities

Quant Pick - Max Financial Services - ICICI Direct

Graphite India - Q2FY21 Result Update - ICICI Direct

Gladiator Stocks - Maruti Suzuki India - ICICI Direct

Exide Industries - Q2FY21 Result Update - ICICI Direct

Mishra Dhatu Nigam - Execution outlook remains strong - ICICI Securities

Bharat Electronics - Diversifying into multiple revenue streams - ICICI Securities

Wipro Ltd - Virtual Analyst Meet Update - ICICI Direct

Avadh Sugar & Energy - November 2020 - Company Update - ICICI Direct

Mahindra Lifespace Developers - H1FY21 Company Update - ICICI Direct

Quant Pick - Godrej Consumer Products - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019